Cargando…
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
In March 2020, the first cases of the human coronavirus disease COVID-19 were registered in Kazakhstan. We isolated the SARS-CoV-2 virus from clinical materials from some of these patients. Subsequently, a whole virion inactivated candidate vaccine, QazCovid-in, was developed based on this virus. To...
Autores principales: | Zhugunissov, Kuandyk, Zakarya, Kunsulu, Khairullin, Berik, Orynbayev, Mukhit, Abduraimov, Yergali, Kassenov, Markhabat, Sultankulova, Kulyaisan, Kerimbayev, Aslan, Nurabayev, Sergazy, Myrzakhmetova, Balzhan, Nakhanov, Aziz, Nurpeisova, Ainur, Chervyakova, Olga, Assanzhanova, Nurika, Burashev, Yerbol, Mambetaliyev, Muratbay, Azanbekova, Moldir, Kopeyev, Syrym, Kozhabergenov, Nurlan, Issabek, Aisha, Tuyskanova, Moldir, Kutumbetov, Lespek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503606/ https://www.ncbi.nlm.nih.gov/pubmed/34646246 http://dx.doi.org/10.3389/fmicb.2021.720437 |
Ejemplares similares
-
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
por: Khairullin, Berik, et al.
Publicado: (2022) -
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022) -
Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
por: Zhugunissov, Kuandyk, et al.
Publicado: (2021) -
Near-Complete Genome Sequence of a SARS-CoV-2 Variant B.1.1.7 Virus Strain Isolated in Kazakhstan
por: Usserbayev, Bekbolat, et al.
Publicado: (2022) -
Lumpy skin disease in Kazakhstan
por: Orynbayev, Mukhit B., et al.
Publicado: (2021)